Prevalence, awareness, treatment and control of hypertension in elderly Chinese

Prevalence, awareness, treatment and control of hypertension in elderly Chinese
复制标题

中国老年人高血压的患病率、知晓率、治疗和控制

DOI:
10.1038/hr.2013.57
复制
发表时间:
2013-09-01
影响因子:
5.4
通讯作者:
Wang, Ji-Guang
Wang, Ji-Guang
中科院分区:
医学2区
文献类型:
--
作者:
Sheng, Chang-Sheng;Liu, Ming;Wang, Ji-Guang

文献摘要

被引文献

相似文献

我们研究了中国老年人群中高血压的患病率、知晓率、治疗和控制情况。研究对象(年龄>= 60岁)于2006年至2008年在上海郊区城镇招募。我们进行了标准化问卷调查,以收集病史,药物使用和生活方式的信息。在受试者以坐姿休息至少5分钟后,我们使用经过验证的Omron 7051示波器(日本京都)连续测量了三次血压。我们将高血压定义为收缩压至少为140 mm Hg或舒张压至少为90 mm Hg或使用抗高血压药物。3949名参与者(平均年龄68.3岁)包括2185名(55.3%)女性,182名(4.6%)肥胖受试者(体重指数>= 30 kg m(-2))和366名(9.3%)糖尿病患者。高血压患病率为59.4%。在2345例高血压患者中,知晓、治疗和控制(≥ 300 g/周,OR 2.18,P=0.0007)。总之,在中国老年人中,高血压的患病率很高。尽管知晓率和治疗率相当高,但控制率仍然很低,这很可能是由于不健康的生活方式和抗高血压药物使用不足和/或剂量不足。
We studied the prevalence, awareness, treatment and control of hypertension in an elderly Chinese population. The study subjects (age >= 60 years) were recruited from a suburban town of Shanghai from 2006 to 2008. We administered a standardized questionnaire to collect information on medical history, the use of medications and lifestyle. We measured blood pressure three times consecutively using a validated Omron 7051 oscillometric device (Kyoto, Japan) after the subjects had rested for at least 5 min in the sitting position. We defined hypertension as a blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic or as the use of antihypertensive drugs. The 3949 participants (mean age of 68.3 years) included 2185 (55.3%) women, 182 (4.6%) obese subjects (body mass index >= 30 kg m(-2)) and 366 (9.3%) diabetic patients. The prevalence of hypertension was 59.4%. In the 2345 hypertensive patients, the awareness, treatment and control (= 300 g per week, OR 2.18, P=0.0007). In conclusion, in elderly Chinese, the prevalence of hypertension is high. In spite of reasonably high awareness and treatment rates, the control rate remains low, most likely due to an unhealthy lifestyle and the underuse and/or underdose of antihypertensive drugs.